Medicine Overview of Gefimipsa Capsule
Gefimipsa 250mg Capsule is used in the treatment of non-small cell lung cancer
It is used in patients in which it has spread to other parts of the body, who have abnormal epidermal growth factor receptor (EGFR) genes, and who have not had previous treatment for cancer.
Nausea, Rash, Vomiting, Weakness, Loss of appetite, Dry skin, Diarrhoea, Stomatitis (Inflammation of the mouth).
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Gefimipsa 250mg Capsule may be taken with or without food, but it is better to take it at a fixed time.
Gefimipsa 250mg Capsule is an anti-cancer medication. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps to stop or slow the spread of cancer cells.
In Depth Information on Gefimipsa Capsule
- Do not take antacids (to reduce the acid level of your stomach) 2 hours before or 1 hour after taking gefitinib.
- Take the tablet at about the same time each day.
- Do not give gefitinib to children.
- Do not take gefitinib, if you are allergic to gefitinib or similar medicines or to any of the other ingredients.
- Avoid using gefitinib, if you are pregnant or are breast-feeding.
- Avoid becoming pregnant during treatment with gefitinib because it could harm your baby.
- If you are taking a medicine containing warfarin as an active substance, your doctor may need to do blood tests more often.
- You may feel weak while taking this medicine, be careful while driving or using tools or machines.
Gefimipsa Capsule related warnings
Interaction with alcohol is unknown. Please consult your doctor.
WEIGH RISKS VS BENEFITS
Gefimipsa 250mg Capsule is unsafe to use during pregnancy.
There is positive evidence of human fetal risk, but the benefits from use in pregnant women may be acceptable despite the risk, for example in life-threatening situations. Please consult your doctor.
Gefimipsa 250mg Capsule is probably unsafe to use during lactation.
Limited human data suggest that the drug could represent a significant risk to the baby.
Do not drive unless you are feeling well.
Gefimipsa 250mg Capsule may make you feel weak. This may affect your driving ability.
Gefimipsa 250mg Capsule should be used with caution in patients with severe kidney disease. Dose adjustment of Gefimipsa 250mg Capsule may be needed. Please consult your doctor.
Gefimipsa 250mg Capsule is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Gefimipsa 250mg Capsule may not be needed in these patients. Please consult your doctor.
If you miss a dose of Gefitinib, skip it and continue with your normal schedule. Do not double the dose.
User Submitted Feedback For Gefimipsa 250mg Capsule
Patients taking Gefimipsa 250mg Capsule What were the side-effects while using this medicine? How do you take this medicine? How much was the improvement? Please rate this medicine on price? What are you using this medicine for?
Non-small cell lung cancer
Survey Participants: 5
“The following are the results of on-going survey on 1mg.com for Gefimipsa 250mg Capsule. These results only indicate the perceptions of the website users. Please base your medical decisions only on the advice of a doctor or a registered medical professional.”
Frequently asked questions about Gefimipsa Capsule
No. It is not a monoclonal antibody.It is a tyrosine kinase inhibitors.
One of the following vendor pharmacies will deliver Gefimipsa 250mg Capsule: IPL, SAF, STA, NSL, TOM, PVP, ABP, SYN, DGN, SJP, GNC, BTM, MSD, RUS, SBA, SHP, HAT, UMP, EMB, PRN, BDN, PPR, SWA, ENP, BSN, RSA, RJH, DHR, MAM, OIP, MPC, RPP, TRP, MMS, SWP, SCH, ZEL, DDR, GPP, THP, AMR, RSS, OLT, GBL, AAY, BAL, SHD, NVL, DLP, WSI, PEN, BHP, HGI, HBV, SRG, 9T9, PWN, ARD, JMJ, NWP, MAX, CLT, SSA, MAK, MLC, PNT, DFP, AGT, ADT, RHL, RHW, RWP, DYG, GTC, MDO, EQN, DPL, ATP, SVH, MOM, NTB, OHM, HMP, NXG, PTI, NDP, NNH, PLT, AYU, TNH, GPT, AAR, WHL, JIV, ZVP, SGC, IAD, BIO, SDM, VRS, HPC, BBS, OWP, ANT, KHH, RKS, DPP, HIP, INC, HEX, ATL, AVN, NVY, SBL, JVO, FGH, BMJ, USF, LCC, SAT, GTK, LHA, JVN